Latest Europe News

Advanced Braking Technology Ltd has kicked off FY26 with a 21% rise in product sales revenue and a 66% jump in net profit before tax, underpinned by expanding international demand and progress in autonomous braking systems.

DroneShield Limited reports a staggering 1,091% revenue increase in 3Q25, driven by booming military and civilian counter-drone demand and strategic expansion of manufacturing and AI-powered SaaS offerings.

GreenX Metals has uncovered a significant 1940 historical copper estimate of 728,000 tonnes at 2.6% grade from its Tannenberg Project in Germany, validated by a 1984 drilling campaign including silver by-product. The discovery supports a modern exploration model and sets the stage for a new drilling program to confirm and upgrade the resource.

Euro Manganese is pushing forward an optimization program for its Chvaletice Manganese Project to enhance operational efficiency and reduce costs, aligning with surging global demand for high-purity manganese critical to electric vehicle batteries and energy storage.

Zoono Group Limited has responded to an ASX price query following a recent surge in its share price and trading volume, confirming no undisclosed information exists and attributing market activity to ongoing shelf-life extension trials across multiple continents.

European Lithium has offloaded an additional US$50 million worth of Critical Metals Corp shares, coinciding with CRML’s own US$50 million capital raise to advance its Greenland rare earth project.

Talga Group has won a SEK 82.6 million (A$13.3 million) grant from the Swedish Energy Agency to advance its low-emission graphite anode project, accelerating its path to commercial-scale production in Sweden.

Vulcan Energy has awarded a €140 million contract to JordProxa for critical lithium purification and processing technology at its Phase One Lionheart Project in Germany, marking a pivotal step towards Europe’s first sustainable lithium supply chain.

PainChek Limited has appointed Sasha Grant as Head of Growth for its AI-powered Infant App, aiming to scale its presence in a $15 billion global market. Early Australian adoption shows promising conversion rates as the company prepares for international expansion.

IMDEX Limited reported a resilient FY25 with steady margins, reduced net debt, and strategic acquisitions positioning it for growth. The company’s FY26 outlook is optimistic, supported by improving global exploration activity and technology adoption.

Health Canada has requested additional information, extending its review of CLINUVEL’s SCENESSE® for erythropoietic protoporphyria (EPP) into 2026. Meanwhile, Canadian patients continue to access the treatment via a Special Access Program.

Anteris Technologies has secured its first European regulatory clearance to commence the global PARADIGM Trial for its DurAVR Transcatheter Heart Valve, marking a significant step toward worldwide commercialization.